Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Conditions:   Liposarcoma;   CRC;   Prostate Cancer;   Breast Neoplasms;   Adenocarcinoma of Lung;   Solid Tumors Interventions:   Drug: PF-07220060;   Combination Product: Letrozole;   Combination Product: Fulvestrant Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials